ALBANY, New York, June 8, 2017 /Weed Wire/ — On June 12, a coalition of community advocates led by the Drug Policy Alliance will join Senator Liz Krueger (New York) and Assemblymember Crystal Peoples-Stokes (Buffalo) to announce reintroduction of the Marijuana Regulation and Taxation Act (MRTA, S.3040/A.3506), which would authorize recreational use of marijuana.
Tag Archives: New York
Cannabis Derivative Cannabidiol Reduces Seizures in Severe Epilepsy Disorder
NEW YORK, May 24, 2017 /Weed Wire/ – After years of anecdotal claims about its benefits, the cannabis derivative cannabidiol reduced seizure frequency 39 percent for patients with Dravet syndrome—a rare, severe form of epilepsy—in the first large-scale, randomized clinical trial for the compound.
Vireo Launches First Marijuana Ad Campaign In NYC Subway History
NEW YORK, May 22, 2017 /Weed Wire/ – Vireo Health of New York (“Vireo”), one of only five medical marijuana companies licensed by New York State, has announced the launch of what is believed to be the first-ever medical marijuana advertising campaign in the history of the New York City subway system.
New York Senate Health Committee Passes Medical Cannabis Bill for PTSD
On May 9, 2017, the New York Senate Health Committee passed Senate Bill 5629, which would consider post-traumatic stress disorder an eligible condition for the state’s medical marijuana program.
New York Adds Patients and Issues List of Medical Marijuana Doctors
On May 5, 2017, the New York State Department of Health gave additional transparency to its program by adding registration statistics and a public list of consenting medical marijuana doctors to the program’s website.
New York State Department of Health Adds Thousands of New Patients to Medical Marijuana Program Following the Addition of Chronic Pain
ALBANY, New York, May 5, 2017 /Weed Wire/ — The New York State Department of Health today announced several milestones in the state’s Medical Marijuana program, including the certification of more than 3,350 patients since the addition of chronic pain as a qualifying condition in late March.
Vireo to Expand Home Delivery of Medical Marijuana to Bronx, State Island and Westchester
NEW YORK, May 5, 2017 /Weed Wire/ — Vireo Health of New York (“Vireo”), one of only five companies licensed by New York State to cultivate, manufacture and dispense medical marijuana, will expand its groundbreaking medical marijuana home delivery program to the Bronx, Staten Island and Westchester County beginning on Saturday, May 6.
New York Medical Marijuana Providers File Suit Against Health Department
On April 28, 2017, four out of five licensed New York medical marijuana providers filed suit against the state Department of Health for attempting to expand the number of licensed providers from five to 10.
MassRoots to Present at the 2017 Canaccord Genuity Cannabis Conference on May 10th
DENVER, May 2, 2017 /Weed Wire/ — MassRoots, Inc. (OTCQB: MSRT), a leading technology platform for medical cannabis patients and businesses, is pleased to announce that its Chairman and Chief Executive Officer, Mr. Isaac Dietrich, will be presenting at the 2017 Canaccord Genuity Cannabis Conference on Wednesday, May 10th at 3:30PM ET at The Intercontinental Barclay New York in New York City.
Solis Tek Retains KCSA Strategic Communications as Corporate Communications Counsel
CARSON, Calif. & NEW YORK, N.Y., April 27, 2017 /Weed Wire/ — Solis Tek (OTCQB: SLTK), is a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products and solutions to commercial cannabis growers in legal markets across the U.S., announced today that it has retained KCSA Strategic Communications (KCSA), a leading New York-based communications firm, to create a strategic, corporate communications program to support sales and branding efforts, as well as help the Company communicate its broader vision to the marketplace and investment community.
Vireo Launches New York City & Long Island’s First-Ever Medical Marijuana Home Delivery Program
NEW YORK, April 21, 2017 /Weed Wire/ — Today, Vireo Health of New York (“Vireo”), one of only five companies licensed by New York State to cultivate, manufacture and dispense medical marijuana, will launch New York City and Long Island’s first-ever medical marijuana home delivery program.
Actress Rachael Leigh Cook And Green Point Creative Recreate Classic Anti-Drug PSA With New Goal
NEW YORK April 20, 2017 /Weed Wire/ — Green Point Creative, and director Ryan Kleier from Motiv Creative, have partnered to create the latest PSA in Green Point’s on-going campaign to change discriminatory drug enforcement policies – a recreation of the classic “This Is Your Brain” ad from 1998
Tikun Olam, the World’s Original Medical Cannabis Company, Announces US Expansion of Health & Wellness Brand: Tikun™
NEW YORK, April 20, 2017 /Weed Wire/ — The United States will experience a wellness revolution through a new line of clinically-proven, proprietary cannabis products from Tikun Olam
Governor Cuomo Convenes First-Ever Industrial Hemp Summit to Grow New York’s Agricultural Industry
ALBANY, N.Y., April 18, 2017 /Weed Wire/ — Governor Andrew M. Cuomo today convened the first-ever New York State Industrial Hemp Summit in Ithaca to build on the momentum of the region’s growing agriculture industry as part of the Southern Tier Soaring economic revitalization initiative.
New York Reminds Insurers to Cover Visits Resulting in MMJ Certification
On April 12, 2017, the NYSDFS announced that it has reminded state-authorized health insurers that they must provide coverage for office visits that fall under the insured’s policy of covered services, including those resulting in patients receiving medical marijuana certifications.
DFS Reminds Health Insurers of Their Obligation to Cover Office Visits That Also Include Medical Marijuana Certification Among Other Healthcare Services
ALBANY, N.Y., April 12, 2017 /Weed Wire/ — Department of Financial Services is reminding all insurers authorized to write insurance in New York State that they must provide coverage for office visits for covered services, including those that may result in a medical marijuana certification, as long as the visit was not solely for the purpose of the certification.
West New York Company Grows Marijuana Without the High
A west New York-based biotech company has successfully grown a strain of marijuana that contains zero THC, a feat the company says will transform the medical marijuana industry.
Cannabis Legalization Spawns Diverse Consumer Marketplace
BROOKLYN, N.Y., March 27, 2017 /Weed Wire/ — Tailoring products and services to the different emerging consumer groups and their unique motivations presents a challenge to entrepreneurial cannabis businesses. To help meet this challenge, two marketing veterans are launching RED BOMBr, a strategy consultancy for the cannabis industry, that helps product makers, dispensaries, growers, and investors better understand the opportunities presented by different consumers.
Medical Marijuana, Inc. Investment AXIM Biotech Retains Ora To Manage Upcoming Product Development And Clinical Trials On Glaucoma And Dry Eye Indications
NEW YORK, March 21, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC: AXIM), a world leader in cannabinoid research and development, has retained the services of Ora®, Inc.,
New York State Department of Health Announces Latest Enhancements to Improve Patient Access to Medical Marijuana Program
ALBANY, N.Y., March 16, 2017 /Weed Wire/ — The New York State Department of Health today announced several enhancements to the state’s Medical Marijuana Program that will improve patient access. These measures include authorizing physician assistants to certify patients and adding chronic pain as a qualifying condition.
Medical Marijuana, Inc. Investment Axim Biotech Announces Enrolled Patients Begin Phase II Trial for the Treatment of Irritable Bowel Syndrome (IBS) with CanChew Plus Cannabidiol (CBD) Chewing Gum
NEW YORK, March 7, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (AXIM) has enrolled 40 patients and commenced its Phase II clinical trial for the treatment of irritable bowel syndrome (IBS) with the company’s CanChew Plus® CBD gum.
Israeli Cabinet Approves Proposal to Decriminalize Marijuana
WASHINGTON, March 6, 2017 /Weed Wire/ — On Sunday, Israel took a big step toward decriminalizing adult marijuana use. The Israeli Cabinet approved a proposal that would replace criminal penalties with fines for people who are caught using marijuana in public. The proposal from the Ministries of Justice and Public Security has received support from Prime Minister Benjamin Netanyahu, but still requires approval of the Israeli Parliament before becoming law.
Advocates Push Crucial Legislation to Seal Past Marijuana Possession Convictions
ALBANY, New York, Feb. 28, 2017 /Weed Wire/ — Today, advocates and legislators held a press conference in Albany to demand reprieve for the harm that has been caused by arrests for low-level marijuana possession and mobilize for legislative solutions to keep New York families together.
New York State Assembly Passes Landmark Legislation to Seal Past Marijuana Possession Convictions
ALBANY, N.Y., Feb. 15, 2017 /Weed Wire/ — Yesterday, the New York State Assembly voted in support of A.2142, a bill that will seal the criminal records of people who have been unjustly and unconstitutionally arrested for simple possession of marijuana in public view.
MedMen Acquires New York Medical Marijuana Company
LOS ANGELES, Feb. 2, 2017 /Weed Wire/ — MedMen, a Los Angeles-based cannabis management and investment firm, announced today that it has acquired Bloomfield Industries, Inc., one of only five Registered Organizations licensed to operate a medical marijuana business in the State of New York.
Etain to Offer Discounts to Repeat Medical Marijuana Customers in New York
A New York medical marijuana company plans to offer discounts to repeat customers, according to a Jan. 29, 2017, article in the Times Union of Albany, N.Y. With four dispensaries statewide, Etain is one of five medical marijuana providers in the state. The company will begin a tiered system of discounts starting Jan. 31, 2017.
NY Medical Marijuana Tax Revenue Comes in Lower Than Expected
The low projection in tax revenue signals an administration belief that little will change in the coming months even as the state Department of Health works to expand access for patients, which should, in theory, bring in new revenue.
AXIM Biotech Enters IBS Clinical Trial for Canchew CBD Chewing Gum
NEW YORK, Jan. 18, 2017 /Weed Wire/ — AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC: AXIM), a world leader in cannabinoid research and development, has entered clinical trials on treating irritable bowel syndrome (IBS) with the Company’s CanChew Plus® cannabidiol (CBD) gum at Wageningen University in the Netherlands.
Governor Cuomo to Propose Clarifications to NY State Law Decriminalizing Marijuana Possession
ALBANY, N.Y., Jan. 13, 2017 /Weed Wire/ — Yesterday, Governor Cuomo announced his renewed commitment to decriminalizing marijuana possession in his State of the State Book, which outlines his agenda for the 2017 Legislative Session.
Company Launching Medical Marijuana Delivery in New York
On Jan. 11, 2017, Vireo Health of New York, one of five medical marijuana companies licensed by the state of New York, announced that the New York State Department of Health has approved its medical marijuana delivery program, making it the first company in the state to receive such approval.
Vireo Approved for NY’s First-Ever Medical Marijuana Home Delivery Program
NEW YORK, Jan. 11, 2017 /Weed Wire/ — Today, Vireo Health of New York (“Vireo”), one of only five companies licensed by New York State to cultivate, manufacture and dispense medical marijuana, announced that it received approval from the New York State Department of Health to launch a medical marijuana home delivery program.
MedMen Acquires One of New York’s Struggling Marijuana Providers
On Jan. 9, 2017, MedMen, a turnkey marijuana management company based in California, acquired Bloomfield Industries, one of New York’s five organizations licensed to grow and distribute medical marijuana
Kush Bottles to Participate in Cowen’s Cannabis Colloquium in New York on January 12, 2017
Kush Bottles, Inc. (OTCQB: KSHB), a leading provider of packaging supplies, accessories and branding solutions for the regulated cannabis industry, has been invited to participate in Cowen’s Cannabis Colloquium which is being held in New York City on January 12, 2017.
Blog Reviewer of Children’s Toys Receives Surprise Delivery of Marijuana
Pamela Marks of Valatie, N.Y., reviews children’s toys and clothes on a blog, so she frequently receives shipments from companies hoping for publicity. But opening a Dec. 29, 2016, delivery, expecting to find items from a California toy company, Marks found not toys, but instead seven pounds of marijuana, according to a report posted at CBS6Albany.com.
NYSSCPA Marijuana Symposium: Neil Kaufman Talks Industry
Corporate cannabis lawyer Neil Kaufman talks about the challenges and prospects for CPAs who get involved in New York’s medical marijuana industry in its early stages.
New York Hospitals Stuck Between State And Federal Laws on Medical Marijuana
The state of New York allows five companies to dispense medical marijuana to qualified patients, but most hospitals receive federal funds, so they cannot allow patients to use pot medicinally, according to an article in the Times Herald-Record of Middletown, N.Y. While several states have approved marijuana for medical or adult use, it remains illegal under federal law.
New York to Allow Medical Marijuana Wholesaling
On Dec. 8, 2016, the New York State Department of Health announced several updates to its medical marijuana program, most notably the approval of medical marijuana wholesaling and lifting the cap on the number of available products for patients.
NYSDOH Announces Ability for Wholesaling of Medical Marijuana Products and Removes Cap On Number of Products Available to Patients
ALBANY, N.Y., Dec. 8, 2016 /Weed Wire/ — The New York State Department of Health today announced several enhancements to the state’s Medical Marijuana Program that will improve access for patients, streamline production, increase choice and help lead to reduced costs.
Stanford University Graduates Form New Energy Company to Help Cannabis Industry Go Green
NEW YORK, Dec. 6, 2016 /Weed Wire/ — Scale Energy Solutions is a new company formed by entrepreneurs from Stanford University, the University of Pennsylvania, and the United States Air Force Academy, to serve the energy needs of the indoor cultivation sector of the legal cannabis industry.
Renowned Brand Executive Joins Viridian Advisory Board
NEW YORK, Dec. 2, 2016 /Weed Wire/ — Viridian Capital Advisors is pleased to announce that Peter J. McDonough has joined our advisory board.
New York Adding Chronic Pain as Qualifying Condition for MMJ
On Dec. 1, 2016, the New York State Department of Health announced that it will be adding chronic pain to the list of qualifying conditions for medical marijuana.
NYSDOH Announces Chronic Pain to Be Added As Qualifying Condition for Medical Marijuana
NEW YORK, Dec. 1, 2016 /Weed Wire/ — The New York State Department of Health today announced that chronic pain will be added as a qualifying condition for medical marijuana.
Stoners No More: Upscale Purchasers of Brand Name Cannabis Products Break Stereotypes and Change the Marijuana Marketplace
NEW YORK, Nov. 30, 2016 /Weed Wire/ — A new class of Cannabis Consumers is reshaping marijuana culture. These individuals break the ‘out of it’ stoner stereotype in favor of feeling more ‘present’ and ‘mindful’ while they consume cannabis.
Nurse Practitioners Can Soon Prescribe Marijuana in New York
The change comes as the number of patients using medical marijuana and doctors prescribing it continues to grow.
The Cannabis Industry’s Ivy League of Educational Institutions Opens Enrollment For New York Grow Seminars in December
OAKLAND, Calif., Nov. 21, 2016 /Weed Wire/ — Oaksterdam University, the Ivy League of cannabis education since 2007, will be holding a seminar in New York City for those interested in an education on indoor horticulture practices in the newly legal cannabis industry.
OWC Pharmaceutical Research Advisory Board Member to Participate in the First Bloomberg Intelligence Sponsored Cannabis Event
PETACH TIKVA, Israel, Nov. 18, 2016 /Weed Wire/ — OWC Pharmaceutical Research Corp. (OTCQB: OWCP), (“OWC” or the “Company”), a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today announced that Jeffrey Friedland, a member of the Company’s Advisory Board, will be participating in Bloomberg Intelligence’s first cannabis-related event; Cannabis Trends & Legalization Implications.
New York Braces for Legal Marijuana in Mass.
Bringing marijuana from Massachusetts or Maine to New York, or from any other states where it’s legal, is a violation under New York law.
Cannabis and Hemp Association, NYU Students for Sensible Drug Policy Host State and Industry Heavyweights for NYU Cannabusiness Seminar 2016
NEW YORK, Nov. 2, 2016 /Weed Wire/ — The Cannabis and Hemp Association (CHA)—New York’s leading voice for cannabis and hemp advocacy and industry—teams up with New York University’s Students for Sensible Drug Policy (SSDP) to present the NYU Cannabusiness Seminar 2016.
New York Plans to Expand Struggling Medical Pot Program
The Department of Health, aiming to improve patient access, plans to add five more companies within two years to a fledgling medical marijuana program that began dispensing the drug in January.
Structure of Primary Cannabinoid Receptor is Revealed
NEW YORK, Oct. 20, 2016 /Weed Wire/ — New research is providing a more detailed view into the structure of the human cannabinoid (CB1) receptor.